Skip to content
Research Article Open access CC BY 4.0

Synthesis and Biological Evaluation of Chromene Derivatives as Carbapenem Adjuvants Against MRSA

Anastasia Golovina, Fedor Antipin, Vitaly Osyanin, Dmitry Osipov, Daniil Yakovlev, Olga Terina, Roman Ivanov

Organics · pp. 39–39 · Published 16 Sep 2026

10.3390/org7030039

Abstract

The increasing prevalence of antimicrobial resistance has stimulated interest in non-antibiotic small molecules that can restore or potentiate the activity of established antibacterial agents. In this study, a focused series of low-molecular-weight chromene derivatives was synthesized, structurally characterized, and evaluated primarily as antibacterial adjuvants rather than as stand-alone antibiotics. The experimental strategy was designed to distinguish intrinsic antibacterial activity from potentiating activity in combination with a partner antibiotic. Initial susceptibility testing was followed by combination experiments in selected bacterial strains, with particular emphasis on changes in the minimum inhibitory concentration (MIC) of meropenem or doripenem in the presence of each test compound. Broth microdilution combination assays demonstrated that compound 3a significantly reduced the MIC of meropenem and doripenem against methicillin-resistant Staphylococcus aureus (MRSA). The observed adjuvant effect suggests that chromene scaffolds may serve as promising candidates for the development of next-generation β-lactam enhancers aimed at overcoming carbapenem resistance.

Doripenem Meropenem Carbapenem Antimicrobial Broth microdilution Antibacterial activity Staphylococcus aureus Microbiology

References (15)

  1. 1 Price, 2016, O’Neill Report on Antimicrobial Resistance: Funding for Antimicrobial Specialists Should Be Improved [DOI]
  2. 2 Golovina, A., Antipin, F., Khalymbadzha, I., Terina, O., Yakovlev, D., Fedina, E., and Ivanov, R. (2026). Treatment Options for Metallo-Beta-Lactamase-Producing Enterobacterales in the Era of Increasing Resistance. Int. J. Mol. Sci., 27. [DOI]
  3. 3 de Kraker, M.E.A., Stewardson, A.J., and Harbarth, S. (2016). Will 10 Million People Die a Year Due to Antimicrobial Resistance by 2050?. PLoS Med., 13. [DOI]
  4. 4 Murray, 2022, Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis [DOI]
  5. 5 Belay, W.Y., Getachew, M., Tegegne, B.A., Teffera, Z.H., Dagne, A., Zeleke, T.K., Abebe, R.B., Gedif, A.A., Fenta, A., and Yirdaw, G. (2024). Mechanism of Antibacterial Resistance, Strategies and next-Generation Antimicrobials to Contain Antimicrobial Resistance: A Review. Front. Pharmacol., 15. [DOI]
  6. 6 Golovina, 2024, (Heteroarylmethyl)Benzoic Acids as a New Class of Bacterial Cystathionine γ-Lyase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling [DOI]
  7. 7 Godinho, P.I.C., Pérez-Ramos, P., Gabasa, Y., Cornielle, E., Soto, S.M., Soengas, R.G., and Silva, A.M.S. (2025). Halogenated 3-Nitro-2H-Chromenes as Potential Agents Against Multidrug-Resistant Bacteria. Antibiotics, 14. [DOI]
  8. 8 Wang, 2021, Design and Structural Optimization of Novel 2H-Benzo[h]Chromene Derivatives that Target AcrB and Reverse Bacterial Multidrug Resistance [DOI]
  9. 9 Lukashenko, 2017, Reaction of Push-Pull Enaminoketones and in Situ Generated ortho-Quinone Methides: Synthesis of 3-Acyl-4H-chromenes and 2-Acyl-1H-benzo[f]chromenes as Precursors for Hydroxybenzylated Heterocycles [DOI]
  10. 10 Lukashenko, 2016, Complementary Pairing of o-Quinone Methides with 3-(N,N-Diethylamino)acrolein—Synthesis of 1H-Benzo[f]chromene-2-carbaldehydes [DOI]
  11. 11 Osyanin, 2015, Synthesis of 2-nitro-1H-benzo[f]chromenes [DOI]
  12. 12 Osyanin, 2026, Construction of 2-(2-Cyanovinyl)-1H-benzo[f]chromenes via [4 + 2]-Cycloaddition of Push-pull 1,3-Butadienes with 1,2-Naphthoquinone 1-Methides and Their Use in Heterocyclic Synthesis [DOI]
  13. 13 Korzhenko, 2025, Divergent Behavior of β-Carbonyl-Substituted 1H-Benzo[f]Chromenes Under Henry Reaction Conditions [DOI]
  14. 14 Clinical and Laboratory Standards Institute (2013). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement M100-S23, CLSI.
  15. 15 Shao, 2025, Staphylococcal Drug Resistance: Mechanisms, Therapies, and Nanoparticle Interventions [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.